Effects of hydroxy safflower Yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice

Journal of Traditional Chinese Medicine

Volumn 32, Issue 2, 2012, Pages 243-248

  Xi, Sheng Yan ^a   Zhang, Qian ^b   Liu, Chao Yang ^c   Xie, Hua ^b   Yue, Li Feng ^b   Gao, Xue Min ^b  

^a XIAMEN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c CANCER HOSPITAL   (China)

Author keywords

BGC 823; CD34; Hydroxy safflower yellow A (HSYA); MVD; Transplantation tumor; Tumor capillary angiogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; HYDROXY SAFFLOWER YELLOW A EXTRACT; SAFFLOWER EXTRACT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYDROXY SAFFLOWER YELLOW A; MALE; MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; SAFFLOWER; STOMACH ADENOCARCINOMA; TUMOR CELL;

EID: 84863628187     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60019-9     Document Type: Article

References (24)

1. Xiao WY. Study and Research progression of safflower yellow. Proc Clin Med 2006; 15: 646-649
2. Zhang Q, Niu X, Yan Y, Zhao Y, Jin M, Xie H. Inhibitory action of HSYA on proliferation of HUVEC cultured in vitro. Chin J TCM Pharm 2004; 19: 379-381
3. Xi SY, Zhang Q, Liu CY, Sun HM, Ge GL, Cui W, Xie H, Liu LT, Gao XM. Inhibitory effect of hydroxy saffloryellow-A on transplantation tumor of human gastric adenocarcinoma cell line BGC-823 in nude mice. J Beijing Univ TCM 2009; 32: 331-335
4. Xi SY, Zhang Q, Wang C, Zhang JJ, Gao XM. Discussion of Safflower inhibiting tumor in application and its mechanism of action. Chin Archives TCM 2008; 26: 1916-1917
5. Sanz-Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E, Sanz-Esponera J, Merino MJ. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol 2000; 15: 455-462
6. Weidner N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors. Breast Cancer Res Treat 1999; 36: 169-180
7. Wu BQ, Fang WG. Neoplasm metastasis mechanism and Obstruction-the basis and clinic of carcinomatosis. Hangzhou: Zhejiang Science and Technology Publishing House; 2005: 159-173
8. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275-288
9. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186
10. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biology 2003; 13: 159-167
11. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S, Shiku H. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69: 247-254
12. Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, Mazziotti A, Grigioni WF. Relevance of biologic markers in colorectal carcinoma-a comparative study of a broad panel. Cancer 2002; 94: 647-657
13. Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, O'malley FP. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996; 20: 1260-1265
14. Zhan QM. Molecule oncology. Beijing: People's Medical Publishing House; 2005: 215.
15. Zhu H, Xian LP, Zhang YM, Li XD, Zou DF. Human cancer of the stomach transplanting tumour changes the model of nude mouse research general situation. Eng Sci Techn 2007; 7: 6031-6034
16. Kragh M, Hjarnaa PJ, Bramm E, Kristjansen PE, Rygaard J, Binderup L. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. Int J Oncol 2003; 22: 305-311
17. Hamanol Y, Sugimotol H, Soubasakosl MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res 2004; 64: 1570-1574
18. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathology 1995; 147: 9-19
19. Kimura H, Nakajima T, Kagawa K, Deguchi T, Kakusui M, Katagishi T, Okanoue T, Kashima K, Ashihara T. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998; 18: 14-19
20. Jiang WQ, Zhang XS, Zhu XF, Li ZM. Tumor biotherapeutics. Guangzhou: Guangdong Science and Technology Publishing House; 2006: 327-329
21. Wang WJ. Effect of Decoction of Flos Carthami on tumor histopathology and angiogenesis. Shanxi J TCM 2007; 23: 59-60
22. Gao CX, Ding ZS, Liang BB, Chen NP, Cheng DQ. Study on the effects of Curcumin on angiogenesis. J Chin Med Mater 2003; 26: 499-502
23. Xu XY, Yang LR. Effect of serum contained tranethylpyrazine on proliferation of ECV304. China Tradit Herb Drugs 2004; 35: 1150-1152
24. Wang SM, Xu XY, Chen G, Yang LR. Taohong Siwu decoction II inhibits the angiogenesis and the expressions of VEGF and KDR/FLK-1 in C57BL/6J mice bearing B16 melanoma. Chin J Chin Mater Med 2005; 30: 1866-1869